In a report released today, Jeff Cantwell from Wells Fargo maintained a Hold rating on Cardlytics (CDLX – Research Report), with a price target of $14.00. The company’s shares closed last Wednesday at $16.47, close to its 52-week low of $11.96.
According to TipRanks.com, Cantwell is a 5-star analyst with an average return of 11.5% and a 64.4% success rate. Cantwell covers the Technology sector, focusing on stocks such as TELUS International (CDA), Fidelity National Info, and Bill.com Holdings.
Currently, the analyst consensus on Cardlytics is a Hold with an average price target of $20.75, which is a 48.3% upside from current levels. In a report released today, Craig-Hallum also maintained a Hold rating on the stock with a $15.00 price target.
Cardlytics’ market cap is currently $514.1M and has a P/E ratio of -6.99.
Based on the recent corporate insider activity of 93 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CDLX in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.
Read More on CDLX:
- Rhythm Pharmaceuticals (RYTM) Receives a Hold from Morgan Stanley
- Alliance Global Partners Initiates a Buy Rating on Pangaea Logistics Solutions (PANL)
- Alteryx (AYX) Receives a Hold from Morgan Stanley
- Solana Blockchain Faces Fresh Attack Targeting Phantom and Slope Wallets
- RBC Capital Reaffirms Their Buy Rating on Surgery Partners (SGRY)